-
Something wrong with this record ?
Postnatal Expression Profile of microRNAs Associated with Cardiovascular and Cerebrovascular Diseases in Children at the Age of 3 to 11 Years in Relation to Previous Occurrence of Pregnancy-Related Complications
I. Hromadnikova, K. Kotlabova, L. Dvorakova, L. Krofta, J. Sirc,
Language English Country Switzerland
Document type Journal Article
Grant support
AZV 16-27761A
Agency of Medical Research, Ministry of Health, Prague, Czech Republic
PROGRES Q34
Charles University, Prague, Czech Republic
NV16-27761A
MZ0
CEP Register
Digital library NLK
Full text - Article
NLK
Free Medical Journals
from 2000
Freely Accessible Science Journals
from 2000
PubMed Central
from 2007
Europe PubMed Central
from 2007
ProQuest Central
from 2000-03-01
Open Access Digital Library
from 2000-01-01
Open Access Digital Library
from 2007-01-01
Health & Medicine (ProQuest)
from 2000-03-01
ROAD: Directory of Open Access Scholarly Resources
from 2000
PubMed
30717412
DOI
10.3390/ijms20030654
Knihovny.cz E-resources
- MeSH
- Biomarkers MeSH
- Cerebrovascular Disorders diagnosis genetics MeSH
- Child MeSH
- Cardiovascular Diseases diagnosis genetics MeSH
- Pregnancy Complications MeSH
- Humans MeSH
- MicroRNAs genetics MeSH
- Child, Preschool MeSH
- Gene Expression Regulation MeSH
- Risk Factors MeSH
- ROC Curve MeSH
- Gene Expression Profiling MeSH
- Severity of Illness Index MeSH
- Pregnancy MeSH
- Transcriptome MeSH
- Ultrasonography MeSH
- Check Tag
- Child MeSH
- Humans MeSH
- Male MeSH
- Child, Preschool MeSH
- Pregnancy MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
Children descending from pregnancies complicated by gestational hypertension (GH), preeclampsia (PE) or fetal growth restriction (FGR) have a lifelong cardiovascular risk. The aim of the study was to verify if pregnancy complications induce postnatal alterations in gene expression of microRNAs associated with cardiovascular/cerebrovascular diseases. Twenty-nine microRNAs were assessed in peripheral blood, compared between groups, and analyzed in relation to both aspects, the current presence of cardiovascular risk factors and cardiovascular complications and the previous occurrence of pregnancy complications with regard to the clinical signs, dates of delivery, and Doppler ultrasound examination. The expression profile of miR-21-5p differed between controls and children with a history of uncomplicated pregnancies with abnormal clinical findings. Abnormal expression profile of multiple microRNAs was found in children affected with GH (miR-1-3p, miR-17-5p, miR-20a-5p, miR-21-5p, miR-23a-3p, miR-26a-5p, miR-29a-3p, miR-103a-3p, miR-125b-5p, miR-126-3p, miR-133a-3p, miR-146a-5p, miR-181a-5p, miR-195-5p, and miR-342-3p), PE (miR-1-3p, miR-20a-5p, miR-20b-5p, miR-103a-3p, miR-133a-3p, miR-342-3p), and FGR (miR-17-5p, miR-126-3p, miR-133a-3p). The index of pulsatility in the ductus venosus showed a strong positive correlation with miR-210-3p gene expression in children exposed to PE and/or FGR. Any of changes in epigenome (up-regulation of miR-1-3p and miR-133a-3p) that were induced by pregnancy complications are long-acting and may predispose children affected with GH, PE, or FGR to later development of cardiovascular/cerebrovascular diseases. Novel epigenetic changes (aberrant expression profile of microRNAs) appeared in a proportion of children that were exposed to GH, PE, or FGR. Screening of particular microRNAs may stratify a highly risky group of children that might benefit from implementation of early primary prevention strategies.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19027853
- 003
- CZ-PrNML
- 005
- 20190815114636.0
- 007
- ta
- 008
- 190813s2019 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/ijms20030654 $2 doi
- 035 __
- $a (PubMed)30717412
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Hromadnikova, Ilona $u Department of Molecular Biology and Cell Pathology, Third Faculty of Medicine, Charles University, 10000 Prague, Czech Republic. ilona.hromadnikova@lf3.cuni.cz.
- 245 10
- $a Postnatal Expression Profile of microRNAs Associated with Cardiovascular and Cerebrovascular Diseases in Children at the Age of 3 to 11 Years in Relation to Previous Occurrence of Pregnancy-Related Complications / $c I. Hromadnikova, K. Kotlabova, L. Dvorakova, L. Krofta, J. Sirc,
- 520 9_
- $a Children descending from pregnancies complicated by gestational hypertension (GH), preeclampsia (PE) or fetal growth restriction (FGR) have a lifelong cardiovascular risk. The aim of the study was to verify if pregnancy complications induce postnatal alterations in gene expression of microRNAs associated with cardiovascular/cerebrovascular diseases. Twenty-nine microRNAs were assessed in peripheral blood, compared between groups, and analyzed in relation to both aspects, the current presence of cardiovascular risk factors and cardiovascular complications and the previous occurrence of pregnancy complications with regard to the clinical signs, dates of delivery, and Doppler ultrasound examination. The expression profile of miR-21-5p differed between controls and children with a history of uncomplicated pregnancies with abnormal clinical findings. Abnormal expression profile of multiple microRNAs was found in children affected with GH (miR-1-3p, miR-17-5p, miR-20a-5p, miR-21-5p, miR-23a-3p, miR-26a-5p, miR-29a-3p, miR-103a-3p, miR-125b-5p, miR-126-3p, miR-133a-3p, miR-146a-5p, miR-181a-5p, miR-195-5p, and miR-342-3p), PE (miR-1-3p, miR-20a-5p, miR-20b-5p, miR-103a-3p, miR-133a-3p, miR-342-3p), and FGR (miR-17-5p, miR-126-3p, miR-133a-3p). The index of pulsatility in the ductus venosus showed a strong positive correlation with miR-210-3p gene expression in children exposed to PE and/or FGR. Any of changes in epigenome (up-regulation of miR-1-3p and miR-133a-3p) that were induced by pregnancy complications are long-acting and may predispose children affected with GH, PE, or FGR to later development of cardiovascular/cerebrovascular diseases. Novel epigenetic changes (aberrant expression profile of microRNAs) appeared in a proportion of children that were exposed to GH, PE, or FGR. Screening of particular microRNAs may stratify a highly risky group of children that might benefit from implementation of early primary prevention strategies.
- 650 _2
- $a biologické markery $7 D015415
- 650 _2
- $a kardiovaskulární nemoci $x diagnóza $x genetika $7 D002318
- 650 _2
- $a cerebrovaskulární poruchy $x diagnóza $x genetika $7 D002561
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a předškolní dítě $7 D002675
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a stanovení celkové genové exprese $7 D020869
- 650 _2
- $a regulace genové exprese $7 D005786
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a mikro RNA $x genetika $7 D035683
- 650 _2
- $a těhotenství $7 D011247
- 650 _2
- $a komplikace těhotenství $7 D011248
- 650 _2
- $a ROC křivka $7 D012372
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a stupeň závažnosti nemoci $7 D012720
- 650 _2
- $a transkriptom $7 D059467
- 650 _2
- $a ultrasonografie $7 D014463
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kotlabova, Katerina $u Department of Molecular Biology and Cell Pathology, Third Faculty of Medicine, Charles University, 10000 Prague, Czech Republic. katerina.kotlabova@lf3.cuni.cz.
- 700 1_
- $a Dvorakova, Lenka $u Department of Molecular Biology and Cell Pathology, Third Faculty of Medicine, Charles University, 10000 Prague, Czech Republic. lenka.dvorakova@lf3.cuni.cz.
- 700 1_
- $a Krofta, Ladislav $u Institute for the Care of the Mother and Child, Third Faculty of Medicine, Charles University, 14700 Prague, Czech Republic. ladislav.krofta@upmd.eu.
- 700 1_
- $a Sirc, Jan $u Institute for the Care of the Mother and Child, Third Faculty of Medicine, Charles University, 14700 Prague, Czech Republic. jan.sirc@upmd.eu.
- 773 0_
- $w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 20, č. 3 (2019)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30717412 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190813 $b ABA008
- 991 __
- $a 20190815114904 $b ABA008
- 999 __
- $a ok $b bmc $g 1433002 $s 1066313
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 20 $c 3 $e 20190202 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
- GRA __
- $a AZV 16-27761A $p Agency of Medical Research, Ministry of Health, Prague, Czech Republic
- GRA __
- $a PROGRES Q34 $p Charles University, Prague, Czech Republic
- GRA __
- $a NV16-27761A $p MZ0
- LZP __
- $a Pubmed-20190813